EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells

Anna Laurenzana, Francesca Margheri, Alessio Biagioni, Anastasia Chillà, Nicola Pimpinelli, Jessica Ruzzolini, Silvia Peppicelli, Elena Andreucci, Lido Calorini, Simona Serratì, Mario Del Rosso, Gabriella Fibbi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds